Dublin, June 06, 2022 (GLOBE NEWSWIRE) -- The "Global Cosmetic Surgery and Procedure Market Size, Share & Industry Trends Analysis Report By Procedure Type, By Non-invasive Type, By Invasive Type, By Regional Outlook and Forecast, 2021-2027" report has been added to ResearchAndMarkets.com's offering.
The Global Cosmetic Surgery And Procedure Market size is expected to reach $107.2 billion by 2027, rising at a market growth of 9.8% CAGR during the forecast period.
Cosmetic surgery is a specialized area of medicine that focuses on enhancing one's look through surgical and medicinal methods. All sections of the head, neck, and body can benefit from cosmetic surgery. In addition, cosmetic surgery is opted by the people who want to increase the aesthetic appeal of a functional body part.
The invention of new cosmetic devices through manufactures has resulted in an increase in demand for cosmetic therapies in recent years. The overview of technologically enhanced product lines, such as non-invasive body contouring systems that use fat freezing technology, for example, is expected to generate lucrative growth opportunities.
Botulinum toxin is a naturally present deadly toxic substance with various applications. This toxin is most commonly used for the treatment of painful muscle spasms as well as for cosmetic reasons. Botulinum toxin is also known as Botox and Dysport. The small use of this toxic chemical aids in muscular coordination and this substance is very useful in cosmetic treatments.
Botox injections are known for their capabilities to degrade the appearance of facial creases. These injections are also used to treat excessive sweating (hyperhidrosis), neck spasms (cervical dystonia), an overactive bladder, and lazy eyes. Botox injections may also be useful in the prevention of chronic migraines. Additionally, Botox injections temporarily paralyze muscles by injecting a toxic substance onobotulinumtoxinA. This toxin is made by the microbiota that causes botulism, which is a form of food poisoning. Botulinum toxin was first used in a drug called Botox. AbbotulinumtoxinA (Dysport), rimabotulinumtoxinB (Myobloc), and incobotulinumtoxinA are now among the other products available (Xeomin). These injections are not interchangeable because they slightly different, especially in terms of dosage units.
Along with that, Botox injections block the effects of particular chemical transmission from nerves, most of which end up causing muscles to contract. The most common usage of these injections is to partially rest the facial muscles which end up causing fine lines in the forehead and across the eyes. These injections are used to cure issues that impact the body systems.
Plastic surgery is performed using a variety of instruments such as curettes, Awls, gouges, chisels, and mallets. Depending on their function, these instruments are classified as cutting tools, clutching or carrying instruments, and plungers.
COVID-19 Impact Analysis
The COVID-19 pandemic had a significant impact on the demand for aesthetic medicine. Originally, social distancing and a sharp drop in consumer income harmed the overall aesthetic procedure industry. The market had experienced a period of short-term negative growth as a result of factors such as temporary closures of beauty centers, limited operations, decreased product demand, and disruptions in the production and business chain.
Remote working has enhanced the average time spent on Zoom calls. People are paying too much attention to about their physical appearance. It has created a market for cosmetic procedures, with Botox being one of the most popular. Non-invasive procedures have grown in popularity in recent months, while invasive procedures have declined.
Market driving Factors:
Increasing Technological enhancements and rise in demand for Minimally Invasive Procedures
The Cosmetic Surgery and Services Market is growing in conjunction with technological advancement. This is due to higher knowledge of advanced cosmetic surgery techniques and increased affordability of beauty treatments. Technologies such as Halo laser, combines ablative and non-ablative wavelengths to profit the skin on different levels.
Among the radio wave, micro needling devices are the secret, Infini, vivace, and enzymes. With the advancements in technologies and treatments, the demand for more efficient aesthetic procedures is also increasing across the world. The Cosmetic Surgery and Services Industry is increasing due to the rising preference for minimally invasive procedures.
Massive attention in modeling and a professional life in aviation
Several sectors, such as modeling work and aerospace, are integrally linked to human beauty from the outside. Individual people pursuing a job in these industries must encounter certain standards of beauty. Applicants applying for the job of flight attendant must fulfill the airline's height, skin color, and body shape demands.
When candidates have tattoos and piercings or scar tissue on their bodies, their applications are more often rejected. Participants who wish to pursue these career opportunities make every attempt to satisfy the criteria. Many people is expected to prefer to have cosmetic procedures, but the recovery time and the chances of obtaining scars from stitches during surgeries often inhibit them from using it.
Marketing Restraining Factor:
Strict Regulations and Inadequate Reimbursement
Restrictive laws and inappropriate reimbursement rates are two key factors expected to nullify the expansion of the Cosmetic Surgery and Services Market. Several patients do not seek a recommendation from their general practitioner because they are extremely fearful of an unkind response or believe that plastic procedures are not essentially medical. Self-referral to the treatment center is a more suitable option.
Cosmetic clinics have highly variable standards, but in response to an advertisement, the clinics frequently send representatives to the patient's home. These legislators are not medically qualified, but they suggest operations and book surgery dates, frequently offering a discount if the physician signs right away.
Key Topics Covered:
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Publisher Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
Chapter 4. Global Cosmetic Surgery And Procedure Market by Procedure Type
4.1 Global Non-invasive Market by Region
4.2 Global Cosmetic Surgery And Procedure Market by Non-invasive Type
4.2.1 Global Botox Injections Market by Region
4.2.2 Global Laser Hair Removal Market by Region
4.2.3 Global Soft Tissue Fillers Market by Region
4.2.4 Global Chemical Peel Market by Region
4.2.5 Global Microdermabrasion Market by Region
4.2.6 Global Others Market by Region
4.3 Global Invasive Market by Region
4.4 Global Cosmetic Surgery And Procedure Market by Invasive Type
4.4.1 Global Breast Augmentation Market by Region
4.4.2 Global Liposuction Market by Region
4.4.3 Global Nose Reshaping Market by Region
4.4.4 Global Tummy Tuck Market by Region
4.4.5 Global Eyelid Surgery Market by Region
4.4.6 Global Others Market by Region
Chapter 5. Global Cosmetic Surgery And Procedure Market by Region
Chapter 6. Company Profiles
6.1 Evolus, Inc. (Alphaeon Corporation)
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Research & Development Expenses
6.2 Revance Therapeutics, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental Analysis
6.2.4 Research & Development Expenses
6.3 Cynosure, LLC
6.3.1 Company Overview
6.3.2 Recent strategies and developments:
6.3.2.1 Acquisition and Mergers:
6.3.2.2 Geographical Expansions:
6.4 Alma Lasers Ltd. (Sisram Medical Ltd.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches and Product Expansions:
6.4.5.2 Approvals and Trials:
6.5 Candela Medical Corporation (Syneron Medical Ltd.)
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Acquisition and Mergers:
6.6 Bausch Health Companies, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Lumenis Ltd.
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Product Launches and Product Expansions:
6.8 Galderma S.A.
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Partnerships, Collaborations, and Agreements:
6.8.2.2 Product Launches and Product Expansions:
6.8.2.3 Acquisition and Mergers:
6.9 AbbVie, Inc. (Allergan PLC)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.9.5 Recent strategies and developments:
6.9.5.1 Approvals and Trials:
6.9.5.2 Acquisition and Mergers:
For more information about this report visit https://www.researchandmarkets.com/r/oq9950
Attachment
